Literature DB >> 24972593

Artificial gametes and the ethics of unwitting parenthood.

A Smajdor1, D Cutas2.   

Abstract

In this paper, we explore the ethical and legal implications of a hypothetical use of artificial gametes (AGs): that of taking a person's cells, converting them to AGs and using them in reproduction-without that person's knowledge or consent. We note the common reliance on genetic understandings of parenthood in the law and suggest that injustices may arise if unwitting genetic parents are sued for child support. We draw parallels between the hypothetical use of AGs to facilitate unwitting parenthood and real examples of unwitting parenthood following cases of sperm theft. We also look at the harm that might be caused by becoming a genetic parent, independently of financial obligations, and ask whether such harm should be understood in terms of theft of property. These examples help to highlight some of the current and prospective difficulties for the regulation of genetic and legal parenthood, and show how existing regulatory assumptions are likely to be further challenged by the development of AGs. We conclude by suggesting that the reliance on genetic connections to generate parental responsibility (financial or otherwise) for offspring is flawed and that alternative ways of establishing parental responsibility should be considered. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Coercion; Cryobanking of Sperm, Ova or Embryos; Informed Consent; Interests of Woman/Fetus/Father; Reproductive Medicine

Mesh:

Year:  2014        PMID: 24972593     DOI: 10.1136/medethics-2013-101824

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  1 in total

1.  Ethics of stem cell-derived gametes made in a dish: fertility for everyone?

Authors:  Annelien L Bredenoord; Insoo Hyun
Journal:  EMBO Mol Med       Date:  2017-04       Impact factor: 12.137

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.